New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity - Wikidata - awgldk - TriplyDB

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

http://www.wikidata.org/entity/Q26765483

about

Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin Protocatechuic Aldehyde Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Nox-Mediated Oxidative Stress and Renal Inflammation.Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice.Effect of combination sildenafil and gemfibrozil on cisplatin-induced nephrotoxicity; role of heme oxygenase-1.

P2860

Q28070295-E33B81D8-3155-4031-A4B7-68CF8D4C09E4 Q36275825-9585BCD0-2E9B-4BA9-BFB4-0F81E521E982 Q37302978-7257BDB5-6F72-44D1-8C71-57870ACC41A0 Q37474946-21AE4E3E-B350-4F83-8590-648AB41D97D8 Q47215463-1B1EB29A-3A92-428E-BAD7-1872B29441DD Q55384168-DDC9A154-4A05-4DDD-AEA8-596B72F7E3A1

P2860

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

http://www.wikidata.org/entity/Q26765483

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@ast

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@en

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@nl

type

label

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@ast

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@en

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@nl

prefLabel

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@ast

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@en

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@nl

P1433

Q26765483-1D9DBBA7-B9FA-4E8E-939C-83186BB9784F

P1476

Q26765483-18E7540E-EDC9-4AD2-B27A-B33591C738F9

P2093

Q26765483-315EF0AF-303F-402E-AA8A-6A23C8EB2F61

Q26765483-3CA46CA2-8CA7-449C-94EC-978F314365E5

Q26765483-3DB5C0FB-5F21-46C1-BC8F-60E0AAF2B8B0

Q26765483-65C98F96-781B-4C18-8A6E-FF1B671B734F

Q26765483-8183BA3E-B5C2-4283-BB72-0FF9C6E40088

Q26765483-B8D97EE0-41C9-469E-9256-D8892A4BA186

Q26765483-BE7A7C36-9D06-4A6A-9895-0758A19CA5F8

Q26765483-C4A164D4-E4F5-4784-AA9A-5DDA9BADF214

Q26765483-D7ACD0B2-3850-48A4-AC42-4F43E27219C1

P275

Q26765483-9186D87F-73C8-47CE-9AA7-0FD0AF544998

P2860

Q26765483-080A09DD-4293-4367-9EB9-A9186313ED71

Q26765483-0CA386F2-3B30-4B4D-B3D7-D93F8C430884

Q26765483-11F36E41-DB39-475E-B798-A5F719902A42

Q26765483-14149C67-8B82-45CF-9BB4-A8ED5EF702CA

Q26765483-15B764EA-6247-4919-96B3-19C27A8CF0B0

Q26765483-15CA7E08-71AC-415B-8B35-DD794DC0AFB6

Q26765483-163E2A60-07D0-4256-8B62-14DDB50977A5

Q26765483-1955A0FF-B681-4E2B-BCC5-0785925AD9DA

Q26765483-1B4B1CC8-DA91-40D4-9C8B-2F213C3EFDE8

Q26765483-20BC76B6-DCB9-4C0E-BF92-FECA7B7D8AC4

P304

Q26765483-5CD64E6C-849A-4418-AD9D-B99C1F6994F7

P31

Q26765483-AD1496C0-83DA-4D77-82EE-FAC192E3D32C

Q26765483-E0B5F964-54D9-4977-8EEF-030ADE90A804

P3181

Q26765483-ABDA6093-779F-4ACA-8B0E-E3CEC0F21D3F

P356

Q26765483-C8C1CF5C-8231-4C94-9EEE-F91453CBDB68

P407

Q26765483-58581488-7F7C-4D14-B54D-D77E331FC071

P478

Q26765483-98D13EED-4618-4F5F-B939-D4B42C5EAA42

P50

Q26765483-C26CB716-2BE3-460B-9C60-6319645402C6

P5008

Q26765483-AEFB47FD-CFDB-4F6E-B073-6A52A91AC64E

P577

Q26765483-50239B4D-C4C4-4785-8946-0AB25236F7FC

P5875

Q26765483-A7D9F8FA-7ADC-45FA-8B7D-C2491D5561AD

P698

Q26765483-85530596-BE9E-4975-82FA-FC21857EACA9

P921

Q26765483-1F1BCF94-98AC-448A-8312-DA70573DDE04

Q26765483-7F6A9EB6-0C5A-44B6-9EF3-F49C5AD9FA8B

Q26765483-89050B04-6BBA-43BE-9E6D-AD269D803729

Q26765483-B2F14478-C06B-4490-B1C8-12DF3F8AA49B

P932

Q26765483-AEC6EC7C-6C9C-4AB0-9746-2B00AC073E22

P3181

P356

P1433

BioMed Research International

P1476

New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity

@en

P2093

AiHua Shen

http://www.w3.org/2001/XMLSchema#string

Gi-Su Oh

http://www.w3.org/2001/XMLSchema#string

Hong-Seob So

http://www.w3.org/2001/XMLSchema#string

Hyeok Shim

http://www.w3.org/2001/XMLSchema#string

Hyung-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Kang-Beom Kwon

http://www.w3.org/2001/XMLSchema#string

Sei-Hoon Yang

http://www.w3.org/2001/XMLSchema#string

Su-Bin Lee

http://www.w3.org/2001/XMLSchema#string

Tae Hwan Kwak

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase

SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells

Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins

Acetylation is indispensable for p53 activation

How mitochondria produce reactive oxygen species

The first 30 years of p53: growing ever more complex

NAD+ as a signaling molecule modulating metabolism

P304

4048390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3168869

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/4048390

http://www.w3.org/2001/XMLSchema#string

P407

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289502363

http://www.w3.org/2001/XMLSchema#string

P698

26881219

http://www.w3.org/2001/XMLSchema#string

P921

inorganic compound

renal insufficiency

physiological phenomena

P932

4736397

http://www.w3.org/2001/XMLSchema#string